Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mouse Monoclonal Antibody to PSMA | Login | Mouse Monoclonal Antibody to PSMA | ||||||||||||||||
|
||||||||||||||||||
Mouse Monoclonal Antibody to CD140a | Login | Mouse Monoclonal Antibody to CD140a | ||||||||||||||||
|
||||||||||||||||||
Mouse Monoclonal Antibody to CD140a | Login | Mouse Monoclonal Antibody to CD140a | ||||||||||||||||
|
||||||||||||||||||
Mouse Monoclonal Antibody to CD11C | Login | Mouse Monoclonal Antibody to CD11C | ||||||||||||||||
|
||||||||||||||||||
c-Myc-Tag (HRP) | Login | c-Myc-Tag (HRP) | ||||||||||||||||
|
||||||||||||||||||
Mouse VEGF-A (164) | Login | Mouse VEGF-A (164) | ||||||||||||||||
|
||||||||||||||||||
Human VEGF-B | Login | Human VEGF-B | ||||||||||||||||
|
||||||||||||||||||
Human VEGF-D | Login | Human VEGF-D | ||||||||||||||||
|
||||||||||||||||||
Mouse Angiopoietin-2 | Login | Mouse Angiopoietin-2 | ||||||||||||||||
|
||||||||||||||||||
Human CTGF | Login | Human CTGF | ||||||||||||||||
|
||||||||||||||||||
Human VEGF-C | Login | Human VEGF-C | ||||||||||||||||
|
||||||||||||||||||
Human VEGF (165) | Login | Human VEGF (165) | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Cathepsin F Antibody | Login | Goat anti-Cathepsin F Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-PDCD1 Antibody | Login | Goat anti-PDCD1 Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Pancreatic Polypeptide / PPY Antibody | Login | Goat anti-Pancreatic Polypeptide / PPY Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Spleen tyrosine kinase / SYK Antibody | Login | Goat anti-Spleen tyrosine kinase / SYK Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-HNF4A Antibody | Login | Goat anti-HNF4A Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-MMP7 Antibody | Login | Goat anti-MMP7 Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Clusterin / APOJ Antibody | Login | Goat anti-Clusterin / APOJ Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Plasminogen Activator / PLAU Antibody | Login | Goat anti-Plasminogen Activator / PLAU Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-ERBB3 / HER3 Antibody | Login | Goat anti-ERBB3 / HER3 Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-PTCH (C Terminus) Antibody | Login | Goat anti-PTCH (C Terminus) Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-INDO / IDO Antibody | Login | Goat anti-INDO / IDO Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-P27KIP1 / CDKN1B (C Terminus) Antibody | Login | Goat anti-P27KIP1 / CDKN1B (C Terminus) Antibody | ||||||||||||||||
|
||||||||||||||||||
Goat anti-Tensin 1 / TNS1 Antibody | Login | Goat anti-Tensin 1 / TNS1 Antibody | ||||||||||||||||
|